Kaken Pharmaceutical Co., Ltd.
4521.T
#6436
Rank
A$1.29 B
Marketcap
A$34.25
Share price
-0.13%
Change (1 day)
N/A
Change (1 year)

Kaken Pharmaceutical Co., Ltd. (4521.T) - Total debt

Total debt on the balance sheet as of March 2026 : A$34.84 Million

According to Kaken Pharmaceutical Co., Ltd.'s latest financial reports the company's total debt is A$34.84 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Kaken Pharmaceutical Co., Ltd. - Total debt on balance sheet (from 2008 to 2026)

Total debt by year

Year Total debt Change
2026-03-31A$35.08 M-14.73%
2025-03-31A$41.14 M5.7%
2024-03-31A$38.92 M-9.71%
2023-03-31A$43.1 M2.14%
2022-03-31A$42.2 M-7.8%
2021-03-31A$45.77 M-21.55%
2020-03-31A$58.35 M18.91%
2019-03-31A$49.07 M3.44%
2018-03-31A$47.44 M4.16%
2017-03-31A$45.54 M1.41%
2016-03-31A$44.91 M-26.34%
2015-03-31A$60.97 M34.13%
2014-03-31A$45.46 M-48.06%
2013-03-31A$87.52 M-11.88%
2012-03-31A$99.32 M-0.13%
2011-03-31A$99.44 M-0.55%
2010-03-31A$99.99 M-17.32%
2009-03-31A$0.12 B30.87%
2008-03-31A$92.41 M-6.32%
2007-03-31A$98.65 M-55.83%
2006-03-31A$0.22 B-28.09%
2005-03-31A$0.31 B